HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroaki Okamoto Selected Research

DNA (Deoxyribonucleic Acid)

8/2021Spontaneous reactivation of hepatitis B virus with a frameshift mutation in the precore region in an elderly hepatitis B virus carrier with lifestyle-related diseases.
3/2018Clinical significance of changes in Torque teno virus DNA titer after chemotherapy in patients with primary lung cancer.
1/2015Serum torque teno virus DNA titer in idiopathic pulmonary fibrosis patients with acute respiratory worsening.
11/2014Molecular analysis of the interspousal transmission of hepatitis B virus in two Japanese patients who acquired fulminant hepatitis B after 50 and 49 years of marriage.
8/2013Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.
7/2012A marked decrease in CD4-positive lymphocytes at the onset of hepatitis in a patient with hepatitis-associated aplastic anemia.
7/2010Hepatitis-associated aplastic anemia during a primary infection of genotype 1a torque teno virus.
3/2008Torque teno virus DNA titre elevated in idiopathic pulmonary fibrosis with primary lung cancer.
11/2007High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
8/2007Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroaki Okamoto Research Topics

Disease

69Infections
06/2023 - 09/2002
55Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 09/2009
28Neoplasms (Cancer)
11/2023 - 06/2003
28Hepatitis E
04/2023 - 02/2003
25Hepatitis
04/2023 - 09/2002
15Hepatitis B
05/2024 - 09/2002
14Lung Neoplasms (Lung Cancer)
04/2024 - 05/2002
14Disease Progression
01/2024 - 06/2005
13Small Cell Lung Carcinoma (Small Cell Lung Cancer)
02/2024 - 08/2006
12Hepatocellular Carcinoma (Hepatoma)
10/2023 - 08/2002
11Pneumonia (Pneumonitis)
04/2024 - 01/2007
10Chronic Hepatitis (Chronic Active Hepatitis)
04/2023 - 08/2006
10Neutropenia
01/2020 - 09/2009
10Massive Hepatic Necrosis
01/2018 - 07/2005
8Chronic Hepatitis C
05/2022 - 06/2002
8Viremia
07/2009 - 08/2002
7Interstitial Lung Diseases (Interstitial Lung Disease)
04/2023 - 06/2003
7Febrile Neutropenia
01/2020 - 01/2014
7Hepatitis A (Hepatitis, Infectious)
02/2017 - 03/2004
6Idiopathic Pulmonary Fibrosis
02/2024 - 03/2008
6Virus Diseases (Viral Diseases)
05/2022 - 10/2002
6Glioma (Gliomas)
02/2008 - 09/2004
5Fibrosis (Cirrhosis)
10/2023 - 08/2002
5Thrombocytopenia (Thrombopenia)
01/2020 - 07/2012
4Acute Liver Failure (Fulminant Hepatic Failure)
06/2023 - 02/2017
4Autoimmune Hepatitis
04/2023 - 06/2005
4Neoplasm Metastasis (Metastasis)
01/2023 - 11/2006
4Liver Diseases (Liver Disease)
01/2014 - 08/2002
3Anorexia
01/2020 - 01/2016
3Anemia
01/2020 - 05/2007
3Diarrhea
01/2020 - 12/2009
3Radiation Pneumonitis
01/2020 - 01/2014
3Coinfection
04/2017 - 02/2003
3Hemangioblastoma
03/2007 - 04/2006
3Glioblastoma (Glioblastoma Multiforme)
05/2005 - 01/2004

Drug/Important Bio-Agent (IBA)

37RNA (Ribonucleic Acid)IBA
04/2023 - 08/2002
26AntibodiesIBA
05/2021 - 09/2002
25Carboplatin (JM8)FDA LinkGeneric
04/2024 - 08/2006
20Cisplatin (Platino)FDA LinkGeneric
12/2023 - 12/2009
17Proteins (Proteins, Gene)FDA Link
09/2022 - 10/2004
17DNA (Deoxyribonucleic Acid)IBA
08/2021 - 08/2002
16Immunoglobulin G (IgG)IBA
08/2022 - 02/2003
16Immunoglobulin M (IgM)IBA
08/2021 - 09/2002
14Hepatitis B Surface Antigens (HBsAg)FDA Link
05/2024 - 09/2002
12Docetaxel (Taxotere)FDA Link
09/2023 - 06/2012
12Immunoglobulin A (IgA)IBA
12/2020 - 02/2003
11NucleotidesIBA
02/2022 - 04/2006
10ErbB Receptors (EGF Receptor)IBA
04/2024 - 05/2011
10Pemetrexed (MTA)FDA Link
12/2023 - 10/2013
9Bevacizumab (Avastin)FDA Link
04/2024 - 06/2012
9Etoposide (VP 16)FDA LinkGeneric
04/2024 - 08/2006
9Irinotecan (Camptosar)FDA LinkGeneric
01/2023 - 08/2006
8Ribavirin (Virazole)FDA LinkGeneric
05/2024 - 10/2013
8Tyrosine Kinase InhibitorsIBA
04/2024 - 10/2018
8Antiviral Agents (Antivirals)IBA
02/2022 - 10/2013
8EnzymesIBA
01/2022 - 09/2002
7PlatinumIBA
04/2024 - 01/2011
6Immune Checkpoint InhibitorsIBA
09/2022 - 01/2020
6Alanine Transaminase (SGPT)IBA
04/2020 - 09/2002
6Transaminases (Aminotransferases)IBA
11/2018 - 01/2008
5VaccinesIBA
01/2021 - 11/2003
5Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2021 - 09/2015
5InterferonsIBA
11/2020 - 06/2002
5AntigensIBA
06/2016 - 01/2005
5ProteomeIBA
10/2011 - 10/2004
4130-nm albumin-bound paclitaxelIBA
04/2024 - 01/2020
4pembrolizumabIBA
10/2023 - 12/2020
4Paclitaxel (Taxol)FDA LinkGeneric
09/2023 - 09/2009
4Prednisolone (Predate)FDA LinkGeneric
04/2023 - 06/2005
4glecaprevir and pibrentasvirIBA
05/2022 - 12/2019
4Adrenal Cortex Hormones (Corticosteroids)IBA
11/2021 - 01/2007
4amrubicinIBA
01/2021 - 12/2006
4Biomarkers (Surrogate Marker)IBA
06/2019 - 06/2005
4Immunoglobulin IsotypesIBA
11/2018 - 07/2005
3osimertinibIBA
04/2024 - 12/2022
3Hepatitis A AntibodiesIBA
06/2023 - 08/2006
3Subgenomic RNAIBA
05/2022 - 01/2022
3atezolizumabIBA
01/2022 - 01/2020
3BilirubinIBA
06/2021 - 09/2002
3Gefitinib (Iressa)FDA Link
10/2018 - 05/2011
3Immunoglobulins (Immunoglobulin)IBA
09/2017 - 11/2012
3Messenger RNA (mRNA)IBA
10/2016 - 01/2004
3ImmunosorbentsIBA
08/2015 - 12/2004
3Prothrombin (Factor II)IBA
08/2009 - 07/2005
2Amino AcidsFDA Link
05/2024 - 08/2007
2durvalumabIBA
03/2024 - 01/2024
2nintedanibIBA
02/2024 - 01/2020
2Vinorelbine (Navelbine)FDA LinkGeneric
12/2023 - 01/2020
2SofosbuvirIBA
10/2023 - 10/2019

Therapy/Procedure

41Therapeutics
04/2024 - 05/2005
40Drug Therapy (Chemotherapy)
04/2024 - 05/2002
12Radiotherapy
01/2024 - 05/2007
10Chemoradiotherapy
03/2024 - 06/2012
10Blood Transfusion (Blood Transfusions)
05/2022 - 08/2002
8Liver Transplantation
05/2022 - 11/2003
4Adjuvant Chemotherapy
12/2023 - 11/2018
4Combination Drug Therapy (Combination Chemotherapy)
07/2019 - 08/2006
3Induction Chemotherapy
01/2023 - 12/2009
3Transplantation
01/2020 - 11/2003
3Renal Dialysis (Hemodialysis)
05/2007 - 12/2004